GSK3β inhibition boosts autophagy and promotes toxic protein aggregate clearance, potentially mitigating Alzheimer’s disease and Parkinson’s disease progression (Gu et al., 2019; Wang et al., 2019). This evidence concerns the gene GSK3B and Alzheimer disease.